Inventor · disambiguated record
Douglas Kamen
Also filed as: KAMEN DOUGLAS · KAMEN DOUGLAS E
9 granted patents·4 pending applications·109 citations·filing 2011–2024
84Inventor score
Top patents by PatentIndex Score
13 records- 0197US9173880B2Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodiesDIX DANIEL B·Filed 2011·Granted Nov 3, 2015·96 cites·17 claims
- 0293US10072086B2Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodiesREGENERON PHARMA·Filed 2015·Granted Sep 11, 2018·12 cites·26 claims
- 0387US2025197515A1Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodiesREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0485US11098127B2Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodiesREGENERON PHARMA·Filed 2018·Granted Aug 24, 2021·1 cites·27 claims
- 0584US12440622B2Devices and methods for overfilling drug containersREGENERON PHARMA·Filed 2024·Granted Oct 14, 2025·0 cites·20 claims
- 0681US11918785B2Devices and methods for overfilling drug containersREGENERON PHARMA·Filed 2023·Granted Mar 5, 2024·0 cites·17 claims
- 0777US12077593B2Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodiesREGENERON PHARMA·Filed 2021·Granted Sep 3, 2024·0 cites·27 claims
- 0871US12436152B2Methods for predicting and modulating glycation of a proteinREGENERON PHARMA·Filed 2022·Granted Oct 7, 2025·0 cites·10 claims
- 0966US2025041411A1Stabilized Formulations Containing Anti-BCMA x Anti-CD3 Bispecific AntibodiesREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1066US2024245779A1Methods of modeling liquid protein composition stabilityREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1158US11577025B2Devices and methods for overfilling drug containersREGENERON PHARMA·Filed 2017·Granted Feb 14, 2023·0 cites·22 claims
- 1258US2022332849A1Stabilized Formulations Containing Anti-MUC16 x Anti-CD3 Bispecific AntibodiesREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1356US12472253B2Activin a antibody formulations and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Nov 18, 2025·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Douglas Kamen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →